-
1
-
-
0028578739
-
Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes
-
ARIENTI, E., SULÉ-SUSO, J., MELANI, C., MACCALLI, C., BELLI, F., ILLENI, M.T., ANICHINI, A., CASCINELLI, N., COLOMBO, M.P. and PARMIANI, G., Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum. Gene Ther., 5, 1139-1150 (1994).
-
(1994)
Hum. Gene Ther.
, vol.5
, pp. 1139-1150
-
-
Arienti, E.1
Sulé-Suso, J.2
Melani, C.3
Maccalli, C.4
Belli, F.5
Illeni, M.T.6
Anichini, A.7
Cascinelli, N.8
Colombo, M.P.9
Parmiani, G.10
-
2
-
-
0030045221
-
Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice
-
ARTEAGA, C.L. and HOLT, J.T., Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. Cancer Res., 56, 1098-1103 (1996).
-
(1996)
Cancer Res.
, vol.56
, pp. 1098-1103
-
-
Arteaga, C.L.1
Holt, J.T.2
-
3
-
-
0030890603
-
Mouse CD1-specific NK1 T cells: Development, specificity, and function
-
BENDELAC, A., RIVERA, M.N., PARK, S.-H. and ROARK, J.H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Ann. Rev. Immunol., 15, 535-562 (1997).
-
(1997)
Ann. Rev. Immunol.
, vol.15
, pp. 535-562
-
-
Bendelac, A.1
Rivera, M.N.2
Park, S.-H.3
Roark, J.H.4
-
4
-
-
0020055779
-
Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascites
-
CHEN, W.H., HOROSZEWICZ, J.S., LEONG, S.S., SHIMANO, T., PENETRANTE, R., SANDERS, W.H., BERJIAN, R., DOUGLASS, H.O., MARTIN, E.W. and CHU, T.M., Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro, 18, 24-34 (1982).
-
(1982)
In Vitro
, vol.18
, pp. 24-34
-
-
Chen, W.H.1
Horoszewicz, J.S.2
Leong, S.S.3
Shimano, T.4
Penetrante, R.5
Sanders, W.H.6
Berjian, R.7
Douglass, H.O.8
Martin, E.W.9
Chu, T.M.10
-
5
-
-
0029737924
-
Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines
-
CLARY, B.M., COVENEY, E.C., BLAZER III, D.G., PHILIP, R. and LYERLY, H.K., Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines. Surgery, 120, 178-181 (1996).
-
(1996)
Surgery
, vol.120
, pp. 178-181
-
-
Clary, B.M.1
Coveney, E.C.2
Blazer D.G. III3
Philip, R.4
Lyerly, H.K.5
-
6
-
-
0031087463
-
Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells
-
CLARY, B.M., COVENEY, E.C., PHILIP, R., BLAZER III, D.G., MORSE, M., GILBOA, E. and LYERLY, H.K., Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells. Cancer Gene Ther., 4, 97-104 (1997).
-
(1997)
Cancer Gene Ther.
, vol.4
, pp. 97-104
-
-
Clary, B.M.1
Coveney, E.C.2
Philip, R.3
Blazer D.G. III4
Morse, M.5
Gilboa, E.6
Lyerly, H.K.7
-
7
-
-
0027538181
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
-
DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
-
(1993)
Proc. Nat. Acad. Sci. (Wash.)
, vol.90
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
Golumbek, P.4
Levitsky, H.5
Brose, K.6
Jackson, V.7
Hamada, H.8
Pardoll, D.9
Mulligan, R.C.10
-
8
-
-
0030937295
-
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
-
FARRELL, H.E., VALLY, H., LYNCH, D.M., FLEMING, P., SHELLAM, G.R., SCALZO, A.A. and DAVIS-POYNTER, N.J., Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (Lond.), 386, 510-514 (1997).
-
(1997)
Nature (Lond.)
, vol.386
, pp. 510-514
-
-
Farrell, H.E.1
Vally, H.2
Lynch, D.M.3
Fleming, P.4
Shellam, G.R.5
Scalzo, A.A.6
Davis-Poynter, N.J.7
-
9
-
-
0024416943
-
Thymic ontogeny and selection of αβ and γ/δ T cells
-
FERRICK, D.A., OHASHI, P.S., WALLACE, V., SCHILHAM, M. and MAK, T.W., Thymic ontogeny and selection of αβ and γ/δ T cells. Immunol. Today, 10, 403-407 (1989).
-
(1989)
Immunol. Today
, vol.10
, pp. 403-407
-
-
Ferrick, D.A.1
Ohashi, P.S.2
Wallace, V.3
Schilham, M.4
Mak, T.W.5
-
10
-
-
0029925529
-
Growth retardation and tumour inhibition by BRCA1
-
HOLT, J.T., THOMPSON, M.E., SZABO, C., ROBINSON-BENION, C., ARTEAGA, C.L., KING, M.-C. and JENSEN, R.A., Growth retardation and tumour inhibition by BRCA1. Nature (Genet.), 12, 298-302 (1996).
-
(1996)
Nature (Genet.)
, vol.12
, pp. 298-302
-
-
Holt, J.T.1
Thompson, M.E.2
Szabo, C.3
Robinson-Benion, C.4
Arteaga, C.L.5
King, M.-C.6
Jensen, R.A.7
-
11
-
-
0029146695
-
Gene therapy of metastatic cancer by in vivo retroviral gene targeting
-
HURFORD, R.K., JR., DRANOFF, G., MULLIGAN, R.C. and TEPPER, R.I., Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nature (Genet.), 10, 430-435 (1995).
-
(1995)
Nature (Genet.)
, vol.10
, pp. 430-435
-
-
Hurford R.K., Jr.1
Dranoff, G.2
Mulligan, R.C.3
Tepper, R.I.4
-
12
-
-
0026572736
-
Extrathymic t cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age
-
KENNEDY, J.D., PIERCE, C.W. and LAKE, J.P., Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J. Immunol., 148, 1620-1629 (1992).
-
(1992)
J. Immunol.
, vol.148
, pp. 1620-1629
-
-
Kennedy, J.D.1
Pierce, C.W.2
Lake, J.P.3
-
13
-
-
0031923444
-
Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene
-
KIMURA, M., TAGAWA, M., YOSHIDA, Y., TAKENOUCHI, T., TAKENAGA, K., AZUMA, K., YAMAGUCHI, T., SAISHO, H. and SAKIYAMA, S., Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene. Anticancer Res., 18, 165-170 (1998).
-
(1998)
Anticancer Res.
, vol.18
, pp. 165-170
-
-
Kimura, M.1
Tagawa, M.2
Yoshida, Y.3
Takenouchi, T.4
Takenaga, K.5
Azuma, K.6
Yamaguchi, T.7
Saisho, H.8
Sakiyama, S.9
-
14
-
-
0028826582
-
Protective immunity induced by B7/CD28-costimulated γδ T cells to the EL-4 lymphoma in allogenic athymic mice
-
LI, Y, NEWBY, S.A., JOHNSTON, J.V., HELLSTRM, K.E. and CHEN, L., Protective immunity induced by B7/CD28-costimulated γδ T cells to the EL-4 lymphoma in allogenic athymic mice. J. Immunol., 155, 5705-5710 (1995).
-
(1995)
J. Immunol.
, vol.155
, pp. 5705-5710
-
-
Li, Y.1
Newby, S.A.2
Johnston, J.V.3
Hellstrm, K.E.4
Chen, L.5
-
15
-
-
0024460181
-
Improved retroviral vectors for gene transfer and expression
-
MILLER, A.D. and ROSMAN, G.J., Improved retroviral vectors for gene transfer and expression. BioTechniques, 7, 980-990 (1989).
-
(1989)
BioTechniques
, vol.7
, pp. 980-990
-
-
Miller, A.D.1
Rosman, G.J.2
-
16
-
-
0029841427
-
Oxidative stress by tumor-derived macrophages suppresses the expression of CD3??chain of T-cell receptor complex and antigen-specific T-cell responses
-
OTUJI, M., KIMURA, Y., AOE, T., OKAMOTO, Y. and SAITO, T., Oxidative stress by tumor-derived macrophages suppresses the expression of CD3??chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. nat. Acad. Sci. (Wash.), 93, 13119-13124 (1996).
-
(1996)
Proc. Nat. Acad. Sci. (Wash.)
, vol.93
, pp. 13119-13124
-
-
Otuji, M.1
Kimura, Y.2
Aoe, T.3
Okamoto, Y.4
Saito, T.5
-
17
-
-
0029151012
-
In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta
-
PEPLINSKI, G.R., TSUNG, K., MEKO, J.B. and NORTON, J.A., In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta. Surgery, 118, 185-191 (1995).
-
(1995)
Surgery
, vol.118
, pp. 185-191
-
-
Peplinski, G.R.1
Tsung, K.2
Meko, J.B.3
Norton, J.A.4
-
18
-
-
0027478361
-
Identification of human cancers deficient in antigen processing
-
RESTIFO, N.P., ESQUIVEL, F., KAWAKAMI, Y., YEWDELL, J.W., MUL, J.J., ROSENBERG, S.A. and BENMINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
-
(1993)
J. Exp. Med.
, vol.177
, pp. 265-272
-
-
Restifo, N.P.1
Esquivel, F.2
Kawakami, Y.3
Yewdell, J.W.4
Mul, J.J.5
Rosenberg, S.A.6
Benmink, J.R.7
-
19
-
-
0031025998
-
Gene therapy for cancer: What have we done and where are we going?
-
ROTH, J.A. and CRISTIANO, R.J., Gene therapy for cancer: what have we done and where are we going? J. nat. Cancer Inst., 88, 21-39 (1997).
-
(1997)
J. Nat. Cancer Inst.
, vol.88
, pp. 21-39
-
-
Roth, J.A.1
Cristiano, R.J.2
-
20
-
-
0029154407
-
The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines
-
RUSSELL, D.W., BERGER, M.S. and MILLER, A.D., The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum. Gene Ther., 6, 635-641 (1995).
-
(1995)
Hum. Gene Ther.
, vol.6
, pp. 635-641
-
-
Russell, D.W.1
Berger, M.S.2
Miller, A.D.3
-
21
-
-
0018268096
-
Complement-mediated lysis of type-C virus: Effect of primate and human sera on various retroviruses
-
SHERWIN, S.A., BENVENISTE, R.E. and TODARO, G.J., Complement-mediated lysis of type-C virus: effect of primate and human sera on various retroviruses. Int. J. Cancer, 21, 6-11 (1978).
-
(1978)
Int. J. Cancer
, vol.21
, pp. 6-11
-
-
Sherwin, S.A.1
Benveniste, R.E.2
Todaro, G.J.3
-
22
-
-
0028589416
-
Experimental and clinical studies of cytokine gene-modified tumor cells
-
TEPPER, R.I. and MULÉ, J.J., Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther., 5, 153-164 (1994).
-
(1994)
Hum. Gene Ther.
, vol.5
, pp. 153-164
-
-
Tepper, R.I.1
Mulé, J.J.2
-
24
-
-
0016817004
-
Human serum lyses RNA tumour viruses
-
WELSH, R.M., JR., COOPER, N.R., JENSEN, F.C. and OLDSTONE, M.B.A., Human serum lyses RNA tumour viruses. Nature (Lond.), 257, 612-614 (1975).
-
(1975)
Nature (Lond.)
, vol.257
, pp. 612-614
-
-
Welsh R.M., Jr.1
Cooper, N.R.2
Jensen, F.C.3
Oldstone, M.B.A.4
-
25
-
-
0031435653
-
Reversal of tumor-induced immunosuppression: A new approach to cancer therapy
-
WOJTOWICZ-PRAGA, S., Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J. Immunol., 20, 165-177 (1997).
-
(1997)
J. Immunol.
, vol.20
, pp. 165-177
-
-
Wojtowicz-Praga, S.1
-
26
-
-
0023406213
-
Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity
-
YAMADA, G., KITAMURA, Y., SONODA, H., HARADA, H., TAKI, S., MULLIGAN, R.C., OSAWA, H., DIAMANTSTEIN, T., YOKOYAMA, S. and TANIGUCHI, T., Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J., 6, 2705-2709 (1987).
-
(1987)
EMBO J.
, vol.6
, pp. 2705-2709
-
-
Yamada, G.1
Kitamura, Y.2
Sonoda, H.3
Harada, H.4
Taki, S.5
Mulligan, R.C.6
Osawa, H.7
Diamantstein, T.8
Yokoyama, S.9
Taniguchi, T.10
-
27
-
-
0029794390
-
Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir
-
YANG, L., HWANG, R., PANDIT, L., GORDON, E.M., ANDERSON, W.A. and PAREKH, D., Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir. Ann. Surg., 224, 405-417 (1996).
-
(1996)
Ann. Surg.
, vol.224
, pp. 405-417
-
-
Yang, L.1
Hwang, R.2
Pandit, L.3
Gordon, E.M.4
Anderson, W.A.5
Parekh, D.6
-
28
-
-
0011992409
-
Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities
-
YOKOTA, T., OTSUKA, T., MOSMANN, T., BANCHEREAU, J., DEFRANCE, T., BLANCHARD, D., DE VRIES, J.E., LEE, F. and ARAI, K., Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc. nat. Acad. Sci. (Wash), 83, 2061-2065 (1986).
-
(1986)
Proc. Nat. Acad. Sci. (Wash)
, vol.83
, pp. 2061-2065
-
-
Yokota, T.1
Otsuka, T.2
Mosmann, T.3
Banchereau, J.4
Defrance, T.5
Blanchard, D.6
De Vries, J.E.7
Lee, F.8
Arai, K.9
-
29
-
-
0027203715
-
Treatment of glioma by engineered interleukin 4-secreting cells
-
Yu, J.S., WEI, M.X., CHIOCCA, E.A., MARTUZA, R.L. and TEPPER, R.I., Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res., 53, 3125-3128 (1993).
-
(1993)
Cancer Res.
, vol.53
, pp. 3125-3128
-
-
Yu, J.S.1
Wei, M.X.2
Chiocca, E.A.3
Martuza, R.L.4
Tepper, R.I.5
|